Plasma levels of antioxidant vitamins in patients with acromegaly: A case-control study
dc.contributor.author | Kutbay N.O. | |
dc.contributor.author | Yurekli B.S. | |
dc.contributor.author | Simsir I.Y. | |
dc.contributor.author | Suner A. | |
dc.contributor.author | Seckiner S. | |
dc.contributor.author | Kucukerdonmez O. | |
dc.contributor.author | Saygili F. | |
dc.date.accessioned | 2024-07-22T08:08:59Z | |
dc.date.available | 2024-07-22T08:08:59Z | |
dc.date.issued | 2019 | |
dc.description.abstract | OBJECTIVE: The aim of this study was to compare antioxidant Vitamin C and Vitamin E levels in the non-acromegaly control group and in patients with acromegaly with and without remission. MATERIAL AND METHODS: In this study, 100 cases, acromegaly patients of 57% (n=57, 29F, 28M, mean ages of 49.5±12.1) and control subjects of 43% (n=43, 29F, 14M, mean ages of 49.6±9.2). Acromegaly patients were classified into two groups; active acromegaly (AA; n=33) and controlled acromegaly (CA; n=24). RESULTS: Vitamin C levels were significantly lower in the acromegaly group [7.6 (4.7) mg/L, as median (IQR)] when compared to the control group [12.2 (5.5) mg/L, as median (IQR)] (p <0.001). Vitamin E levels didn't show a significant difference between the acromegaly and the control groups (14.2±3.6 vs. 14.8±3.7, as mean±SD, respectively, p = 0.439). Correlation analysis showed that Vitamin C levels were not significantly associated with clinical, anthropometric and laboratory parameters in the acromegaly group. Vitamin E levels were significantly associated with the total cholesterol, triglyceride, LDL-C, HDL-C, APO Al, APO B both in the acromegaly and the control groups. CONCLUSION: This study is the first one to investigate the relationship between the levels of Vitamin C & E and anthropometric & metabolic parameters in acromegaly patients and control group. In our study, Vitamin C level was significantly lower in the acromegaly group compared to the level in the control group. There was no significant difference in Vitamin E levels between the acromegaly and control group. © 2019 Maghira and Maas Publications. All rights reserved. | |
dc.identifier.issn | 0172780X | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14595 | |
dc.language.iso | English | |
dc.publisher | Maghira and Maas Publications | |
dc.subject | Acromegaly | |
dc.subject | Adipose Tissue | |
dc.subject | Adult | |
dc.subject | Apolipoprotein A-I | |
dc.subject | Apolipoproteins B | |
dc.subject | Ascorbic Acid | |
dc.subject | Body Composition | |
dc.subject | Body Mass Index | |
dc.subject | Case-Control Studies | |
dc.subject | Cholesterol | |
dc.subject | Cholesterol, HDL | |
dc.subject | Cholesterol, LDL | |
dc.subject | Electric Impedance | |
dc.subject | Female | |
dc.subject | Human Growth Hormone | |
dc.subject | Humans | |
dc.subject | Insulin Resistance | |
dc.subject | Insulin-Like Growth Factor I | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Receptors, Somatotropin | |
dc.subject | Triglycerides | |
dc.subject | Vitamin E | |
dc.subject | Waist Circumference | |
dc.subject | alpha tocopherol | |
dc.subject | apolipoprotein A1 | |
dc.subject | apolipoprotein B | |
dc.subject | ascorbic acid | |
dc.subject | cholesterol | |
dc.subject | high density lipoprotein cholesterol | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | pegvisomant | |
dc.subject | triacylglycerol | |
dc.subject | alpha tocopherol | |
dc.subject | apolipoprotein A1 | |
dc.subject | apolipoprotein B | |
dc.subject | ascorbic acid | |
dc.subject | cholesterol | |
dc.subject | growth hormone receptor | |
dc.subject | high density lipoprotein cholesterol | |
dc.subject | human growth hormone | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | pegvisomant | |
dc.subject | somatomedin C | |
dc.subject | triacylglycerol | |
dc.subject | acromegaly | |
dc.subject | adult | |
dc.subject | anthropometric parameters | |
dc.subject | Article | |
dc.subject | case control study | |
dc.subject | cholesterol blood level | |
dc.subject | clinical feature | |
dc.subject | controlled study | |
dc.subject | correlation analysis | |
dc.subject | diabetes mellitus | |
dc.subject | disease duration | |
dc.subject | female | |
dc.subject | glucose intolerance | |
dc.subject | high performance liquid chromatography | |
dc.subject | human | |
dc.subject | hypertension | |
dc.subject | impaired glucose tolerance | |
dc.subject | impedance | |
dc.subject | laboratory test | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | medical history | |
dc.subject | metabolic parameters | |
dc.subject | patient | |
dc.subject | remission | |
dc.subject | smoking | |
dc.subject | triacylglycerol blood level | |
dc.subject | vitamin blood level | |
dc.subject | acromegaly | |
dc.subject | adipose tissue | |
dc.subject | blood | |
dc.subject | body composition | |
dc.subject | body mass | |
dc.subject | insulin resistance | |
dc.subject | metabolism | |
dc.subject | middle aged | |
dc.subject | waist circumference | |
dc.title | Plasma levels of antioxidant vitamins in patients with acromegaly: A case-control study | |
dc.type | Article |